Melatonin for Insomnia in Children with ADHD: What Research Shows
Sleep-onset insomnia is common in children with ADHD. Research has examined melatonin for its potential to support sleep onset, duration, and related outcomes in this population under medical supervision.*
By Bruce Brightman – Founder – LifeSource Vitamins
Many children with ADHD struggle with chronic difficulty falling asleep, which can affect daytime behavior, mood, and quality of life. Melatonin has been studied as a potential option to support sleep in this group, including longer-term use.
Essential Insights
- Sleep-onset insomnia is frequent in children with ADHD and can worsen daytime symptoms.
- Melatonin has been studied for potential improvements in sleep onset, total sleep time, and related outcomes.
- Some studies report improvements in behavior and mood alongside better sleep.
- Studied doses showed generally good tolerability, but use requires healthcare provider guidance.
What the Research Shows – Clinical Evidence
Long-term follow-up and other clinical studies have examined melatonin for chronic sleep-onset insomnia in children with ADHD. These studies assess effectiveness, sleep parameters, and safety over time.
Key Human Clinical Studies
- Hoebert M et al., 2009 (Long-term follow-up of 94 children with ADHD and chronic sleep-onset insomnia) Melatonin was judged effective against sleep onset problems in 88% of cases over an average of 3.7 years. Improvements in behavior (71%) and mood (61%) were reported by many parents. No serious adverse events or treatment-related co-morbidities were noted. Discontinuation usually led to relapse of sleep onset insomnia. NIH/PubMed — Hoebert M, 2009
- Checa-Ros A et al., 2023 (Open-label trial in 27 children/adolescents with ADHD on stimulants) Low-dose melatonin (1 mg) for 4 weeks was associated with increased total sleep time, with only minor transient side effects reported. NIH/PMC — Checa-Ros A, 2023
- Masi G et al., 2019 (Naturalistic study in 74 children with ADHD on methylphenidate) Adding melatonin (mean ~1.85 mg/day) for at least 4 weeks improved sleep disorders in 60.8% of patients per clinical global impression, with no reported side effects. NIH/PMC — Masi G, 2019
These studies suggest melatonin may support improvements in sleep onset and duration for many children with ADHD and insomnia, with some reporting benefits in behavior and mood. Long-term follow-up showed continued effectiveness for a majority without serious adverse events. Results vary by individual, and discontinuation often leads to relapse. Larger controlled trials are needed to confirm optimal use and long-term outcomes.
Evidence Strength: Moderate / Long-term Follow-up & Open-label
Article Integrity: Written by Bruce Brightman. Reviewed by the LifeSource Vitamins Research & Formulation Team.